Stock Taper
OPPORTUNITY RADAR
SCREENER
COMPARE ANY 2 STOCKS
Pricing
Log In
SIGN UP
EARNINGS CALL ARCHIVE
4 CALLS ON FILE
BBNX
— Beta Bionics, Inc.
NASDAQ
FULL STOCK PAGE →
Q2 2026 Earnings Call Summary
JUL 29, 2026
REVENUE
$32.0M
+15.9%
NET MARGIN
-73.1%
+6.2 PTS
EPS
-$0.53
-8.2%
FREE CASH FLOW
-$15.7M
+37.9%
No summary has been written for this call yet.
← NEWER CALL
CALL 1 OF 4
OLDER CALL →